Advantage Alpha Capital Partners LP Ironwood Pharmaceuticals Inc Transaction History
Advantage Alpha Capital Partners LP
- $515 Million
- Q1 2024
A detailed history of Advantage Alpha Capital Partners LP transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Advantage Alpha Capital Partners LP holds 130,966 shares of IRWD stock, worth $814,608. This represents 0.22% of its overall portfolio holdings.
Number of Shares
130,966
Previous 125,705
4.19%
Holding current value
$814,608
Previous $1.44 Million
20.72%
% of portfolio
0.22%
Previous 0.28%
Shares
2 transactions
Others Institutions Holding IRWD
# of Institutions
296Shares Held
170MCall Options Held
27.1MPut Options Held
2.28M-
Black Rock Inc. New York, NY24.2MShares$150 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.5MShares$121 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$102 Million24.97% of portfolio
-
State Street Corp Boston, MA13.9MShares$86.6 Million0.01% of portfolio
-
Pacer Advisors, Inc. Malvern, PA7.21MShares$44.8 Million0.16% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $953M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...